Predictive Oncology Inc (POAI)

$14.32 +0.22 (1.60%)
Market Cap 10.76M
Revenue (ttm) 1.62M
Net Income (ttm) -12.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -781.48%
Debt to Equity Ratio 0.00
Volume 96,700
Avg Vol 94,266
Day's Range N/A - N/A
Shares Out 763,000.00
Stochastic %K 15%
Beta 1.32
Analysts Hold
Price Target $3.00

Company Profile

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and...

Industry: Health Information Services
Sector: Healthcare
Phone: 412 432 1500
Address:
91 43rd Street, Suite 110, Pittsburgh, United States
Vikingsstrade
Vikingsstrade Oct. 3 at 5:29 PM
$POAI $LNAI $ORKT $LESL Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
dogood
dogood Oct. 3 at 4:26 PM
$POAI let’s get to $20
0 · Reply
WinningDaily3
WinningDaily3 Oct. 3 at 2:22 PM
$POAI
1 · Reply
dogood
dogood Oct. 3 at 11:13 AM
$POAI will she cross $20 today
0 · Reply
Iraji
Iraji Oct. 3 at 2:11 AM
$IFBD $POAI $TLRY
0 · Reply
BullseyeStock
BullseyeStock Oct. 3 at 1:35 AM
GIPR is the type of setup market is loving right now. When more folks finds this, expecting big things! Float is very small on it, so will go up fast! Be early bulls, GIPR has the parabolic look! GIPR ✅Partnerships = increase revenues ✅Go private = They are undervalued currently compared to peers and revenues ✅Joint venture = would increase share price tremendously ✅Sale of the company = they would get probably 4x-5x minimum their yearly revenues. banked $TNMG $NVNI $POAI $MSS
1 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 11:44 PM
$POAI $LNAI $ORKT $LESL .
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:15 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $RAYA $POAI $LNAI $ORKT .
0 · Reply
bioebi
bioebi Oct. 2 at 5:30 PM
$BLIN $DVLT $ATCH $POAI BLIN: Low Float, AI Technology / Products, Major partnerships, Insider buying activities
0 · Reply
stuk
stuk Oct. 2 at 4:51 PM
$POAI There should be an announcement that its closed otherwise its not going much further prob AH can be fun if its released the news of it. GLTA DYOR
0 · Reply
Latest News on POAI
Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens

Sep 29, 2025, 9:07 AM EDT - 5 days ago

Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens

Predictive Oncology Announces 1-for-15 Reverse Stock Split

Sep 25, 2025, 8:00 AM EDT - 9 days ago

Predictive Oncology Announces 1-for-15 Reverse Stock Split

Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients

Sep 4, 2025, 9:00 AM EDT - 4 weeks ago

Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients

PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Aug 19, 2025, 9:44 PM EDT - 6 weeks ago

PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 14, 2025, 7:00 AM EDT - 7 weeks ago

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

Jul 8, 2025, 9:00 AM EDT - 3 months ago

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

Jun 12, 2025, 8:30 AM EDT - 4 months ago

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

Court Denies Renovaro Motion for an Expedited Trial in July

May 27, 2025, 8:35 AM EDT - 4 months ago

Court Denies Renovaro Motion for an Expedited Trial in July

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition

May 22, 2025, 8:15 AM EDT - 4 months ago

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"

May 20, 2025, 8:30 AM EDT - 4 months ago

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 15, 2025, 7:00 AM EDT - 5 months ago

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

Apr 1, 2025, 7:00 AM EDT - 6 months ago

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

Mar 25, 2025, 7:00 AM EDT - 6 months ago

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries

Mar 20, 2025, 7:00 AM EDT - 7 months ago

Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries

Predictive Oncology Closes Registered Direct Offering

Feb 19, 2025, 5:20 PM EST - 8 months ago

Predictive Oncology Closes Registered Direct Offering

Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing

Feb 18, 2025, 8:00 AM EST - 8 months ago

Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing

Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform

Feb 12, 2025, 2:00 PM EST - 8 months ago

Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform

AIRNA Appoints Matthew Hawryluk as Chief Business Officer

Jan 30, 2025, 7:00 AM EST - 8 months ago

AIRNA Appoints Matthew Hawryluk as Chief Business Officer

Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay

Jan 16, 2025, 8:00 AM EST - 9 months ago

Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Jan 7, 2025, 6:51 PM EST - 9 months ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Predictive Oncology Announces Agreement to be Acquired by Renovaro

Jan 6, 2025, 9:10 AM EST - 9 months ago

Predictive Oncology Announces Agreement to be Acquired by Renovaro

Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update

Nov 13, 2024, 7:00 AM EST - 11 months ago

Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update

Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 5, 2024, 8:00 AM EDT - 1 year ago

Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 12:47 PM EDT - 1 year ago

Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call Transcript

Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 14, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update

Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

Aug 7, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds

Jul 26, 2024, 8:00 AM EDT - 1 year ago

Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds

Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results

Jul 25, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results

Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)

Jun 11, 2024, 8:00 AM EDT - 1 year ago

Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)

Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery

Jun 4, 2024, 8:42 AM EDT - 1 year ago

Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery

Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024

May 29, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024

Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

May 28, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call Transcript

May 15, 2024, 5:34 PM EDT - 1 year ago

Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call Transcript

Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update

May 15, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024

May 10, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 10:25 AM EDT - 1 year ago

Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

Mar 28, 2024, 5:28 PM EDT - 1 year ago

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

Predictive Oncology to Participate in Upcoming Investor Conferences

Feb 21, 2024, 4:05 PM EST - 1 year ago

Predictive Oncology to Participate in Upcoming Investor Conferences

Predictive Oncology to Participate in Upcoming San Francisco Conferences

Jan 2, 2024, 7:00 AM EST - 1 year ago

Predictive Oncology to Participate in Upcoming San Francisco Conferences

Predictive Oncology Inc. (POAI) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 1:27 PM EST - 2 years ago

Predictive Oncology Inc. (POAI) Q3 2023 Earnings Call Transcript

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 14, 2023, 7:00 AM EST - 2 years ago

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

Nov 8, 2023, 8:12 AM EST - 2 years ago

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

Predictive Oncology, Inc. (POAI) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 11:56 PM EDT - 2 years ago

Predictive Oncology, Inc. (POAI) Q2 2023 Earnings Call Transcript

Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 10, 2023, 5:15 PM EDT - 2 years ago

Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update

Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023

Aug 3, 2023, 8:00 AM EDT - 2 years ago

Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023

Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh

Jul 18, 2023, 8:00 AM EDT - 2 years ago

Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh

Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board

Jun 27, 2023, 8:00 AM EDT - 2 years ago

Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board

Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board

Jun 20, 2023, 8:00 AM EDT - 2 years ago

Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board

Vikingsstrade
Vikingsstrade Oct. 3 at 5:29 PM
$POAI $LNAI $ORKT $LESL Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
dogood
dogood Oct. 3 at 4:26 PM
$POAI let’s get to $20
0 · Reply
WinningDaily3
WinningDaily3 Oct. 3 at 2:22 PM
$POAI
1 · Reply
dogood
dogood Oct. 3 at 11:13 AM
$POAI will she cross $20 today
0 · Reply
Iraji
Iraji Oct. 3 at 2:11 AM
$IFBD $POAI $TLRY
0 · Reply
BullseyeStock
BullseyeStock Oct. 3 at 1:35 AM
GIPR is the type of setup market is loving right now. When more folks finds this, expecting big things! Float is very small on it, so will go up fast! Be early bulls, GIPR has the parabolic look! GIPR ✅Partnerships = increase revenues ✅Go private = They are undervalued currently compared to peers and revenues ✅Joint venture = would increase share price tremendously ✅Sale of the company = they would get probably 4x-5x minimum their yearly revenues. banked $TNMG $NVNI $POAI $MSS
1 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 11:44 PM
$POAI $LNAI $ORKT $LESL .
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:15 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $RAYA $POAI $LNAI $ORKT .
0 · Reply
bioebi
bioebi Oct. 2 at 5:30 PM
$BLIN $DVLT $ATCH $POAI BLIN: Low Float, AI Technology / Products, Major partnerships, Insider buying activities
0 · Reply
stuk
stuk Oct. 2 at 4:51 PM
$POAI There should be an announcement that its closed otherwise its not going much further prob AH can be fun if its released the news of it. GLTA DYOR
0 · Reply
Unalloyed
Unalloyed Oct. 2 at 4:41 PM
$POAI Looks like it's starting.
1 · Reply
PhiloftheFuture
PhiloftheFuture Oct. 2 at 4:39 PM
$POAI added to my portfolio today. EV is not representative of reality
1 · Reply
Najoua233902
Najoua233902 Oct. 2 at 3:57 PM
$POAI the private placement is due to close today
1 · Reply
stuk
stuk Oct. 2 at 3:55 PM
$POAI Movement started keep an eye DYOR
0 · Reply
stuk
stuk Oct. 2 at 3:52 PM
$POAI I said before as well this will linger around here and even after such big news about BTC its still hovering and when no one expects it will explode DYOR GLTA
0 · Reply
Truth_baller
Truth_baller Oct. 2 at 1:59 PM
$POAI We are experts at driving in reverse
0 · Reply
BullsEyePick
BullsEyePick Oct. 2 at 4:54 AM
Looking for the next Monster runner?🚨🚨 Make sure you have ticker IVDA on ur watch. IVDA is Truly a gem of a ticker, known for big runs and perfect for a market like this where this can go on a massive rally of 400-500%+. IVDA has everything going for it, news/approved crypto treasury/Ai /Drone and most important of all it's a low float ticker. Be early bulls, because it will take off fast! $ZKIN $OSRH $INEO $POAI
0 · Reply
davis8uni
davis8uni Oct. 2 at 3:15 AM
$POAI
0 · Reply
Joshkdunn
Joshkdunn Oct. 1 at 8:57 PM
$POAI everyone hope on board and short this baby all the way down. Big money
0 · Reply
ChristianW
ChristianW Oct. 1 at 7:57 PM
$POAI a ticker clinging to relevance. Investors deserve better.
0 · Reply
KLINSY
KLINSY Oct. 1 at 7:19 PM
$POAI Trend on vwap PR 2 oct boom
0 · Reply
TheDarkCity
TheDarkCity Oct. 1 at 6:56 PM
$POAI We are going to revolutionize the way the world finds and treats cancer with our bio bank.... naawww... scratch that... Let's pivot to what really matters... managing a single token crypto treasury.... yeah, that's it... no distractions. no products. no customers. just uncut Web3... oh, and more silly investors to burn.
0 · Reply